Page last updated: 2024-10-26

ebastine and Pink Eye

ebastine has been researched along with Pink Eye in 1 studies

Research Excerpts

ExcerptRelevanceReference
" Furthermore, it has been shown that improved clinical efficacy can be attained with an increased dosage of 20 mg daily in comparison to the usual dosage of 10 mg/day without increasing the rate of side effects."2.73[New generation antihistamines as monotherapy or in combination. What is the relevance for daily clinical routine for allergic rhinoconjunctivitis]. ( Köberlein, J; Mösges, R, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mösges, R1
Köberlein, J1

Trials

1 trial available for ebastine and Pink Eye

ArticleYear
[New generation antihistamines as monotherapy or in combination. What is the relevance for daily clinical routine for allergic rhinoconjunctivitis].
    HNO, 2007, Volume: 55, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Butyrophenones; Conjunctivitis; Drug Combinations; Female; Germany;

2007